Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Digestive Diseases

The Latest in Diagnosis and Treatment of Gastrointestinal Disorders

Vol. 34, No. 1-2, 2016

Issue release date: March 2016

Inflammatory Bowel Disease: East Meets West

Falk Symposium 198, Shenzhen, September 2015: Official Congress Report

See also ISBN 978-3-318-05827-7 for more details
Add all to MyReading List
 
1

Title Page / Table of Contents

Dig Dis 2016;34:1-4 (DOI:10.1159/000444038)
Free Access
I

Preface

Rogler G.
Dig Dis 2016;34:I (DOI:10.1159/000444177)
Genetic Risk Factors in IBD: Do They Play the Same Role in East and West?
5

Risk Genes of Inflammatory Bowel Disease in Asia: What Are the Most Important Pathways Affected?

Guo C. · Wu K.
Dig Dis 2016;34:5-11 (DOI:10.1159/000442917)
12

The Promise of Epigenetics. Has It Delivered New Insights?

Cho J.H.
Dig Dis 2016;34:12-19 (DOI:10.1159/000442919)
20

Environment and Genes: What Is the Interaction?

Blumberg R.S.
Dig Dis 2016;34:20-26 (DOI:10.1159/000442920)
IBD: Environmental Contributions to Disease Onset in East and West?
27

Links of Autophagy Dysfunction to Inflammatory Bowel Disease Onset

El-Khider F. · McDonald C.
Dig Dis 2016;34:27-34 (DOI:10.1159/000442921)
35

Hygiene Hypothesis: Is the Evidence the Same All Over the World?

Leong R.W. · Mitrev N. · Ko Y.
Dig Dis 2016;34:35-42 (DOI:10.1159/000442922)
The Mucosal Innate Immune System: What Does It Teach Us for the Development of New Therapy
43

Endothelial Cell-Immune Cell Interaction in IBD

Danese S. · Fiocchi C.
Dig Dis 2016;34:43-50 (DOI:10.1159/000442925)
51

Dendritic Cell-T-Cell Circuitry in Health and Changes in Inflammatory Bowel Disease and Its Treatment

Knight S.C.
Dig Dis 2016;34:51-57 (DOI:10.1159/000442926)
Open Access Gateway
Environmental Triggers for Disease Onset: Can We Avoid Them?
58

Psychological Stress and Depression: Risk Factors for IBD?

Bernstein C.N.
Dig Dis 2016;34:58-63 (DOI:10.1159/000442929)
64

An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?

Burman S. · Hoedt E.C. · Pottenger S. · Mohd-Najman N.-S. · Ó Cuív P. · Morrison M.
Dig Dis 2016;34:64-71 (DOI:10.1159/000443759)
72

Smoking and Diet: Impact on Disease Course?

Cosnes J.
Dig Dis 2016;34:72-77 (DOI:10.1159/000442930)
78

High Altitude Journeys, Flights and Hypoxia: Any Role for Disease Flares in IBD Patients?

Vavricka S.R. · Rogler G. · Biedermann L.
Dig Dis 2016;34:78-83 (DOI:10.1159/000442932)
84

IBD and Environment: Are There Differences between East and West

Gearry R.B.
Dig Dis 2016;34:84-89 (DOI:10.1159/000442933)
Treatment Decisions: Common Markers in East and West?
90

ASCA, ANCA, ALCA and Many More: Are They Useful in the Diagnosis of Inflammatory Bowel Disease?

Zhou G. · Song Y. · Yang W. · Guo Y. · Fang L. · Chen Y. · Liu Z.
Dig Dis 2016;34:90-97 (DOI:10.1159/000442934)
98

Calprotectin or Lactoferrin: Do They Help

Wright E.K.
Dig Dis 2016;34:98-104 (DOI:10.1159/000442935)
105

Iron Deficiency, Zinc, Magnesium, Vitamin Deficiencies in Crohn's Disease: Substitute or Not?

Kruis W. · Phuong Nguyen G.
Dig Dis 2016;34:105-111 (DOI:10.1159/000443012)
The Basics of IBD Therapy
112

Practical Considerations and the Intestinal Microbiome in Disease: Antibiotics for IBD Therapy

Fedorak R.N. · Ismond K.P.
Dig Dis 2016;34:112-121 (DOI:10.1159/000443014)
122

Oral or Topical 5-ASA in Ulcerative Colitis

Hanauer S.B.
Dig Dis 2016;34:122-124 (DOI:10.1159/000443026)
125

When to Start Immunomodulators in Inflammatory Bowel Disease?

Sharara A.I.
Dig Dis 2016;34:125-131 (DOI:10.1159/000443127)
132

Anti-TNFs: Originators and Biosimilars

Mantzaris G.J.
Dig Dis 2016;34:132-139 (DOI:10.1159/000443128)
New Options / Treatment Goals for IBD Therapy
140

Methotrexate for Inflammatory Bowel Diseases - New Developments

Herfarth H.H.
Dig Dis 2016;34:140-146 (DOI:10.1159/000443129)
Free Access
147

‘Treat to Target' - Lessons Learnt

Kurti Z. · Vegh Z. · Golovics P.A. · Lakatos P.L.
Dig Dis 2016;34:147-152 (DOI:10.1159/000443131)
153

Anti-Integrins in Ulcerative Colitis and Crohn's Disease: What Is Their Place?

Khanna R. · Mosli M.H. · Feagan B.G.
Dig Dis 2016;34:153-159 (DOI:10.1159/000443132)
160

Mucosal Healing - How Deep Is Enough?

Iacucci M. · Ghosh S.
Dig Dis 2016;34:160-164 (DOI:10.1159/000443133)
Biologicals and Beyond
165

Personalizing IBD Therapy: The Asian Perspective

Yang S.-K.
Dig Dis 2016;34:165-174 (DOI:10.1159/000443134)
175

The Future of IBD Therapy: Where Are We and Where Should We Go Next?

Mao R. · Hu P.-J.
Dig Dis 2016;34:175-179 (DOI:10.1159/000443135)
 
180

Falk Symposium Series

Dig Dis 2016;34:180-182 (DOI:10.1159/000444041)
Free Access
183

Author Index Vol. 34, No. 1-2, 2016

Dig Dis 2016;34:183 (DOI:10.1159/000444039)
Free Access
184

Subject Index Vol. 34, No. 1-2, 2016

Dig Dis 2016;34:184 (DOI:10.1159/000444040)
Free Access